| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA129158
Max Phase: Preclinical
Molecular Formula: C24H27NO2
Molecular Weight: 361.49
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: COc1ccc(/C=C2\C(C)=C(CCN3CCOCC3)c3ccccc32)cc1
Standard InChI: InChI=1S/C24H27NO2/c1-18-21(11-12-25-13-15-27-16-14-25)22-5-3-4-6-23(22)24(18)17-19-7-9-20(26-2)10-8-19/h3-10,17H,11-16H2,1-2H3/b24-17+
Standard InChI Key: RRIVHTQLWXZTQY-JJIBRWJFSA-N
Associated Targets(non-human)
Prostaglandin-H2 D-isomerase 67 Activities
Mus musculus 284745 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Cannabinoid receptor 174 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 361.49 | Molecular Weight (Monoisotopic): 361.2042 | AlogP: 4.75 | #Rotatable Bonds: 5 |
| Polar Surface Area: 21.70 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 7.44 | CX LogP: 4.27 | CX LogD: 3.95 |
| Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.77 | Np Likeness Score: -0.70 |
References
| 1. Kumar V, Alexander MD, Bell MR, Eissenstat MA, Casiano FM, Chippari SM, Haycock DA, Luttinger DA, Kuster JE, Miller MS, Stevenson JI, Ward SJ. (1995) Morpholinoalkylindenes as antinociceptive agents: Novel cannabinoid receptor agonists, 5 (4): [10.1016/0960-894X(95)00040-Z] |
Source
Source(1):